Indication

Non-Hodgkin's lymphoma

Non-Hodgkin's lymphoma is a diverse group of hematologic malignancies originating from lymphoid tissues, primarily affecting B lymphocytes and less commonly T lymphocytes or natural killer (NK) cells. Read more about Non-Hodgkin's lymphoma

487 drugs 205 manufacturers

Advertisement

Drugs that treat it

Common Non-Hodgkin's lymphoma therapies.

Showing 262–270 of 487 drugs

Filter & compare in the drug finder →Opens the drug finder with Non-Hodgkin's lymphoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Non-Hodgkin's lymphoma.

Non-Hodgkin's lymphoma is a diverse group of hematologic malignancies originating from lymphoid tissues, primarily affecting B lymphocytes and less commonly T lymphocytes or natural killer (NK) cells.

This disease directly involves the lymphatic and immune systems, frequently manifesting as painless lymphadenopathy in the neck, axillae, or groin, with potential dissemination to the spleen, bone marrow, and extranodal organs.

Pathophysiologically, it is driven by genetic mutations that cause the uncontrolled clonal proliferation, survival, and accumulation of abnormal lymphocytes without the presence of diagnostic Reed-Sternberg cells.

Clinically, it ranges from indolent to aggressive forms and often presents with systemic "B symptoms," including persistent fever, drenching night sweats, and unintentional weight loss.

Personalize your experience

Follow Non-Hodgkin's lymphoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it